Fera Pets Is Betting Longevity Science Sells Better Than 'Joint Support'

Fera Pets is launching two new supplement SKUs at SuperZoo 2026: Longevity for Dogs and Healthy Weight & Muscles for Dogs, both daily soft chews formulated around emerging longevity science rather than the joint-and-digestion playbook most supplement brands run.

The decision: target categories positioned differently than what's already on the shelf

Fera Pets, founded by veterinarian Dr. Michelle Dulake, is positioning the line around cellular health, mitochondrial function, and metabolic support, language borrowed from human longevity supplements, not the pet aisle. The Longevity formula combines ingredients the company says support brain health, antioxidant defense, and cellular energy production. The Healthy Weight & Muscles formula pairs what Fera calls "clinically studied muscle-support ingredients" with microbiome-focused metabolic science.

The company describes the products as "next-generation" and says they're designed for pet parents seeking "proactive, science-forward ways to support their dogs' healthspan." Fera will preview both at booth #2803.

Who this squeezes

Fera's entry doesn't displace an existing brand so much as it asks the buyer to create a new micro-category: longevity and metabolic support as distinct from joint health, digestion, and skin-and-coat. That's a harder ask than replacing an underperforming SKU in a category the store already stocks.

The vet-founder credential is the wedge. Dr. Dulake's quote in the announcement frames the products as "formulas truly worthy" of pet parents' intention to do more for their dogs, and positions the ingredients, NMN, MitoPrime, phosphatidylserine, MyHMB, as molecular-level science rather than category filler. Whether that credential converts shelf space depends on whether the buyer believes "longevity" is a category pet parents will ask for by name, or whether it's a brand story that dies at the endcap.

If you're deciding what to walk at SuperZoo, subscribe to PetRetailNews.

Our read: this works if the buyer already believes the human longevity trend crosses over

Fera is not betting on supplement buyers. It's betting on buyers who watch the human wellness space and believe pet parents will follow the same trajectory, from reactive treatment (joint support after the dog limps) to proactive optimization (cellular health before anything breaks).

That's a real bet, not a safe one. If pet parents treat their dogs the same way they treat themselves when it comes to longevity supplements, Fera's positioning is early to a category shift. If they don't, if "longevity" stays a human buzzword and pet parents keep buying glucosamine, then Fera is a premium SKU in search of a category that doesn't exist yet.

The company says the products are "rooted in both clinical insight and everyday usability," which is the language of a brand trying to justify a price point. No pricing in the announcement, but the ingredient list and the vet-founder story both signal premium. The question for the buyer is whether the pet parent walking into your store knows what NMN is, or whether you're the one who has to explain it.

What changes on the shelf Monday

Nothing, unless you're the buyer Fera is pitching at SuperZoo. If you stock supplements and you're walking the show, add booth #2803 to the list and ask three questions:

1. What's the retail price, and what's your cost?
2. Which of my current SKUs would you replace, or are you asking me to expand the set?
3. What does sell-through look like for the brands already running this play, the ones positioning around cellular health or metabolic optimization rather than joint support?

If the answer to question three is "we're the first," you're not evaluating a product. You're evaluating whether you believe a category is about to exist.

← Back to the Newsdesk